Related Experiment Video
Updated: May 5, 2026

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.7K
[Hyperglycaemic crises in children and adolescents].
1Haga Ziekenhuis, locatie Juliana Kinderziekenhuis, afd. Kindergeneeskunde, Den Haag.
Nederlands Tijdschrift Voor Geneeskunde
|December 12, 2013
Summary
The new Dutch guideline for pediatric diabetic ketoacidosis (DKA) and hyperglycemic hyperosmolar syndrome (HHS) emphasizes slow rehydration and careful metabolic correction to prevent cerebral edema in DKA and prioritize fluid replacement for HHS.
Area of Science:
- Pediatric Endocrinology
- Metabolic Disorders
- Clinical Guidelines
Background:
- Diabetic ketoacidosis (DKA) involves hyperglycemia, ketosis, and acidosis, with cerebral edema as a severe complication.
- Hyperglycemic hyperosmolar syndrome (HHS) is marked by hyperglycemia, hyperosmolarity, dehydration, and potential multi-organ failure.
- A new guideline from the Paediatric Association of the Netherlands (NVK) addresses DKA and HHS treatment in children.
Purpose of the Study:
- To outline the NVK's updated recommendations for managing DKA and HHS in pediatric patients.
- To differentiate treatment strategies for DKA and HHS, contrasting with other guidelines.
- To provide evidence-based approaches for preventing complications like cerebral edema.
Main Methods:
- The guideline distinguishes between DKA and HHS treatment protocols.
- Recommendations focus on the pace and type of fluid administration for rehydration.
- Specific guidance is provided on insulin dosage and timing for both conditions.
Main Results:
- Preventing cerebral edema in DKA requires slow rehydration and metabolic correction; hypotonic fluids are not advised.
- In DKA, correcting hyperglycemia is secondary to careful rehydration, with low-dose insulin initiation.
- For HHS, initial treatment prioritizes correcting intravascular hypovolemia through fluid replacement; insulin is considered if glucose levels do not adequately decrease.
Conclusions:
- The NVK guideline provides distinct, cautious approaches to DKA and HHS management in children.
- Slow, careful fluid and metabolic correction are key to preventing DKA complications.
- Aggressive fluid resuscitation is the primary intervention for HHS, with insulin as a secondary consideration.
More Related Videos
Related Concept Videos
Hyperglycemia
25
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose...
25
Hypoglycemia and Glucagon
1.3K
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.3K
Hypoglycemia
30
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
30
Complications of Diabetes Mellitus
35
Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
35
Type I Diabetes III: Clinical Manifestations
26
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the...
26
Hyperosmolar Hyperglycemic State
20
Hyperosmolar Hyperglycemic State, or HHS, is a serious and life-threatening complication of type 2 diabetes mellitus. It is characterized by three main features: severe hyperglycemia, profound dehydration, and elevated serum osmolality, all occurring without significant ketoacidosis.HHS typically develops in older adults or individuals with limited access to fluids. This may result from illness, cognitive impairment, or medications such as diuretics or corticosteroids. These factors reduce...
20

